Neurovirt

What Neurovirt does

NeuroVirt Limited is a UK-based medical device company that has developed an extended reality (XR) rehabilitation platform for patients recovering from stroke and other neurological conditions including Parkinson's, Multiple Sclerosis, Cerebral Palsy, Traumatic Brain Injury, and Spinal Cord Injury. The platform combines immersive VR and Augmented Reality environments, head-mounted displays, sensor technology, and AI-enabled motion tracking to deliver gamified upper- and lower-limb therapy. Core proprietary capabilities include MotionCheck (real-time compensation detection and correction), an Adaptive Difficulty System that personalises exercises to patient progress, automated instant assessments that replace manual therapist measurement, and a clinician-facing WebApp dashboard for remote patient monitoring, outcome reporting, and cohort analytics.

The product is co-designed with patients and clinicians, with input from over 500 patients and 350 clinicians to date, and validated through an SBRI Healthcare randomised feasibility trial (ISRCTN54249743, 36 stroke survivors) and a Part B intensive rehabilitation study. Reported clinical outcomes include 30% better improvement in movement outcomes, 65% increase in grip strength, 29% greater intrinsic motivation, and 200% increase in rehabilitation dose versus usual care. NeuroVirt holds a full medical device regulatory stack (ISO 13485, ISO 27001, FDA 21 CFR Part 820, CE, UKCA, NHS DTAC, DCB0129, Cyber Essentials, CSA STAR).

The company sells through direct enterprise field sales to NHS sites, private rehabilitation clinics, and US academic hospitals (including UCLH, Cedars Sinai, Mount Sinai, Hobbs Rehabilitation, Circle Rehabilitation, Royal Hospital for Neurodisability), complemented by a direct-to-patient home-use channel. Revenue is generated via subscription/licensing of the software platform, hardware sales (VR headsets and sensors), and managed telerehabilitation services, although pricing is quote-based and not publicly disclosed. As of 2025 NeuroVirt employs 1-10 people across London, Belfast, and New York, and has raised approximately $4.7M cumulatively across grants (SBRI Healthcare, Innovate UK, NIHR, i4i-connect) and equity rounds (Genesis Ventures in early 2024 and L-Stone Capital's $1.89M round in March 2025).

Name

Neurovirt

Legal name

NeuroVirt Limited

Website

https://neurovirt.io

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

NeuroVirt is a UK medical device company that provides an XR (VR/AR) rehabilitation platform with AI-enabled motion tracking and real-time compensation correction for stroke and neurological patients, serving NHS hospitals, private rehabilitation clinics, US academic medical centers, and individual home users.

Ownership category

akta.pro rank

Product category

XR Rehabilitation Software

NAICS

Vocational Rehabilitation Services (62431), Services for the Elderly and Persons with Disabilities (624120)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845), Services-Home Health Care Services (8082)

akta.pro primary industry

Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ), Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

Keywords

• XR rehabilitation software
• Neurorehabilitation platform
• VR physical therapy
• Motion tracking technology
• Clinical rehabilitation tools

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. XR Rehabilitation Platform Licensing: NeuroVirt provides its XR rehabilitation platform for clinical and home use, likely through subscription or licensing arrangements. The platform includes games, motion tracking, and the clinician WebApp dashboard.
2. Hardware Sales: VR headsets and sensors for clinical and home use, enabling the XR rehabilitation experience.
3. Remote Monitoring Services: Telerehabilitation and remote monitoring capabilities for home-based programs with clinician oversight.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

NeuroVirt provides a mixed-reality (XR) rehabilitation platform that combines virtual reality, augmented reality, sensor technology, and AI-powered motion tracking to deliver high-intensity upper and lower limb rehabilitation for stroke survivors and patients with neurological conditions. The platform includes gamified therapy exercises, real-time compensation tracking, a clinician WebApp dashboard, and remote patient monitoring capabilities for use in clinical settings and at home.

Product overview

NeuroVirt is a unified XR rehabilitation platform combining a core mixed reality platform with modular components. The NeuroVirt XR Platform serves as the central system, with the NeuroVirt WebApp providing clinician oversight and the MotionCheck module enabling real-time compensation tracking. The platform is organized into Upper Limb Games (Boxing, Saw, Butterfly Catching, Buzz, Maze, Shooting, Music, Cooking) and Lower Limb Games (Cycling, Dancing, Painting), all powered by AI for adaptive difficulty and real-time feedback. The platform targets neurological conditions including stroke, TBI, SCI, Parkinson's, MS, and cerebral palsy, and is designed for both clinical and home use.

Differentiator

Problem solved

Functional benefit

Products and services

• NeuroVirt XR Platform A mixed reality (XR) solution for upper and lower limb rehabilitation that combines gamified exercises, real-time motion tracking, AI-enabled feedback, and remote patient monitoring with compensation tracking. Designed for clinical and home use, targeting stroke survivors and patients with neurological conditions including Parkinson's, Multiple Sclerosis, Cerebral Palsy, Spinal Cord Injury, and Traumatic Brain Injury.

Quantifiable outcome

• 30% better improvement in clinical movement outcomes vs usual care
• +5 more outcomes

Named customers15 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• UEA (University of East Anglia)coreStrategic or Co-development PartnerAcademic research partner contributing to the scientific foundation and clinical validation of NeuroVirt's XR rehabilitation technology.
• UCL (University College London)coreStrategic or Co-development PartnerAcademic origin of NeuroVirt - founder Dr. Eve Gregoriou completed PhD in Clinical & Movement Neurosciences at UCL. Research and development partnership.
• University of NottinghammajorStrategic or Co-development PartnerAcademic partner supporting research and development of NeuroVirt rehabilitation technology.
• Hobbs RehabilitationcoreStrategic or Co-development PartnerClinical partner for co-design and trials - 40 stroke survivors recruited from Hobbs for initial co-design study (Jan-Jun 2022). Ongoing clinical implementation partner.
• UCLHmajorStrategic or Co-development PartnerUniversity College London Hospitals - NHS hospital trust partnership for clinical implementation and validation.
• Circle RehabilitationmajorChannel Partner/ Reseller/ DistributorPartner rehabilitation clinic network implementing NeuroVirt technology for patient care.
• ReachminorStrategic or Co-development PartnerResearch/partnership network supporting rehabilitation technology development and implementation.
• NorfolkminorStrategic or Co-development PartnerRegional health/care partnership supporting NeuroVirt implementation.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• XRHealth: XRHealth provides FDA-cleared VR-based rehabilitation and telehealth platforms for neurological and orthopedic conditions, closely matching NeuroVirt's XR rehabilitation offering, target clinical customers, and home-based remote monitoring model.
• MindMaze: MindMaze develops FDA-cleared digital therapeutics and VR/AR neurorehabilitation platforms for stroke, brain injury, and motor recovery, making it a direct competitor in clinical neuro-rehab XR with similar patient populations and reimbursement pathways.
• Penumbra (REAL Immersive System): Penumbra's REAL System is an FDA-cleared immersive VR rehabilitation product for upper extremity stroke and neuro recovery sold into US hospitals and clinics, directly competing with NeuroVirt's XR rehabilitation platform in similar indications.
• Saebo: Saebo specializes in upper-limb rehabilitation equipment and digital tools for stroke survivors, including VR-based therapy programs, overlapping with NeuroVirt's upper-limb neurological rehab focus and clinical customer base.
• Constant Therapy Health: Constant Therapy provides digital cognitive, speech, and language therapy, increasingly extending into motor/neuro rehabilitation with clinician dashboards, sharing NeuroVirt's evidence-based digital therapy approach for neurological patient populations.

Broad incumbents

• Hinge Health: Hinge Health is a large digital MSK and chronic pain platform with remote therapeutic monitoring, employer and payer distribution, and AI-guided exercise programs; it operates at greater scale in adjacent rehabilitation but does not focus on acute neuro/stroke populations.
• Sword Health: Sword Health is a digital MSK and pelvic health therapy platform with AI-powered remote monitoring and insurer/payer contracts, comparable in its digital-first rehab and remote monitoring model but serving musculoskeletal rather than neurological conditions.

Emerging players

• Flint Rehab: Flint Rehab develops music- and sensor-based neurorehabilitation tools (e.g., MusicGlove, FitMi) targeting stroke and upper-limb recovery, with a similar home-use digital rehab focus and overlapping neurological patient segment.
• Neuroelectrics: Neuroelectrics builds EEG-guided brain stimulation and neurotechnology platforms for neurological conditions, partially overlapping with NeuroVirt's neuroscience-rooted, clinically validated neurorehabilitation positioning.

Others

• Cue Health: Cue Health is a digital health company with FDA clearances and remote patient monitoring infrastructure; thematically related as an FDA-cleared, clinically validated digital therapeutics player navigating US reimbursement, though operating in diagnostics rather than rehabilitation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

• Xtwitter.com/NeuroVirt
• Facebookfacebook.com/people/NeuroVirt/61573831004910/?_rdr
• LinkedInuk.linkedin.com/company/neurovirt-limited
• Instagraminstagram.com/neurovirt_rehab

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds10 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neurovirt